Abstract
The rapid growth in the number of oncological diseases justifies the need to create new therapeutic agents and methods. Photodynamic therapy has a wide range of treatments for superficial diseases due to the inability to penetrate more than 3 mm of laser light into tissues. The aim of the study was to characterize the physicochemical properties of a new PEI-E6-DTPA-FA-Eu molecular conjugate based on the europium-modified Сhlorin E6 photosensitizer and to evaluate its phototoxic effect on Ehrlich ascitic tumor cells. It has been established that under 5-minute irradiation with a wavelength of 645 nm and an energy of 6 J/cm2, the synthesized molecular conjugate PEI-E6-DTPA-FA-Eu generates reactive oxygen species 5.1 times more intensively than free Chlorin E6. On the 4th day after photodynamic exposure with PEI-E6-DTPA-FA-Eu, the cell death rate was 75%, while with Chlorin Е6 it was only 24%.
Similar content being viewed by others
REFERENCES
P. Grosjean, G. Wagnieres, C. Fontolliet, et al., Br. J. Cancer 11, 1989 (1998).
A. Lambert, L. Nees, S. Nuyts, et al., Front. Oncol. 11, 518 (2021). https://doi.org/10.3389/fonc.2021.626394
R. L. Yanovsky, D. W. Bartenstein, G. S. Rogers, et al., Photoderm. Photoimmun. Photomed. 35, 295 (2019). https://doi.org/10.1111/phpp.12489er.2010.07.007
N. J. Collier and L. E. Rhodes, Molecules 22, 5398 (2020).
O. V. Korshunova and N. G. Plekhova, Tikhookean. Med. Zh. 4, 15 (2020). https://doi.org/10.34215/1609-1175-2020-4-15-19
O. V. Shevchenko, V. I. Apanasevich, and P. A. Luk’yanov, Izvestiya SPbGTI. 52, 23 (2020). https://doi.org/10.36807/1998-9849-2020-52-78-23-27
N. I. Steblevskaya, M. A. Medkov, and M. V. Belobeletskaya, Russ. J. Inorg. Chem. 65, 329 (2020). https://doi.org/10.1134/S0036023620030171
H. Yang, R. M. Villani, H. Wang, et al., J. Exp. Clinical Cancer Res. 37, 1 (2018). https://doi.org/10.1186/s13046-018-0909-x
S. Kamiloglu, G. Sari, T. Ozdal, et al., Food Front. 3, 332 (2020). https://doi.org/10.1002/fft2.44
A. M. Rieger, K. L. Nelson, and J. D. Konowalchuk, JoVE 50, e2597 (2011). https://doi.org/10.3791/2597
Ö. Özdemir, Allerg. Immunopath. 5, 259 (2011). https://doi.org/10.1016/j.aller.2010.07.007
Z. Kuluncsics, D. Perdi, E. Brulay, et al., J. Photochem. Photobiol. B 1, 71 (1999). https://doi.org/10.1016/S1011-1344(99)00130-X
M. Fernández, F. Javaid, and V. Chudasama, Chem. Sci. 4, 790 (2018). https://doi.org/10.1039/C7SC04004K
J. A. Ledermann, S. Canevari, and T. Thigpen, Ann. Oncol. 10, 2034 (2015). https://doi.org/10.1093/annonc/mdv250
R. Prasad, S. B. Agawane, D. S. Chauhan, et al., Bioconjugate Chem. 12, 4012 (2018).
O. Modupe, J. B. Maurras, and L. L. Diosady, J. Agricult. Food Res. 2, 100060 (2020).
R. R. Allison and K. Moghissi, Clin. Endosc. 1, 24 (2013).
L. Benov, Med. Princ. Pract. 24, 14 (2015).
Funding
The reported study was funded by the Russian Foundation for Basic Research, project no. 20-33-90185.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Shevchenko, O.V., Plekhova, N.G., Medkov, M.A. et al. Europium-Containing Conjugate for Photodynamic Therapy of Malignant Neoplasms. Russ. J. Inorg. Chem. 67, 1361–1367 (2022). https://doi.org/10.1134/S003602362209011X
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S003602362209011X